Nebius Group (NBIS) shares plunge on Friday, as the stock was swept up in a broader market downturn ths is hammering technology stocks across the board.
Bitcoin (CRYPTO: BTC) is down 8% on the week, with historical cycle analysis suggesting further downside ahead, according to crypto analyst Benjamin Cowen.
Microsoft stock dropped 12% Thursday amid concerns over AI spending returns. Despite Azure's 30%+ quarterly revenue growth, it may fall short. Bullish investors can leverage yesterday's unusual options activity with two call strategies to exploit the...
Lean hog futures are down 10 to 35 cents at midday. USDA’s national base hog price was reported at $83.89 on Friday morning, down 49 cents from the previous day. The CME Lean Hog Index was up another 50 cents on Jan 28 at $85.72. USDA’s pork carcass...
Corn futures are falling back lower on Friday, with contracts down 5 to 5 ½ cents in the front months at midday. The CmdtyView national average Cash Corn price is down 5 cents at $3.90 1/2. The outside markets are playing a role, with the dollar inde...
Soybeans are trading with 10 to 11 point losses in the front months on Friday. The cmdtyView national average Cash Bean price is 2 3/4 cents lower at $10.05. Soymeal futures are $3 to $3.30 lower, with Soy Oil futures 60 points lower. USDA Export Sal...
Cotton futures are down 34 to 51 points at midday. Crude oil futures were up $0.85 per barrel on the day at $64.57. The US dollar index was back up $0.718 to $96.855. Cotton export commitments are 7.553 million RB as of 1/22, down 13% from a year ag...
The wheat complex is trading with losses across the three markets on Friday. Chicago SRW futures are 6 to 7 cents in the red at midday. KC HRW futures are falling back 5 to 6 cents in the front months. MPLS spring wheat is down 5 to 6 cents at...
Live cattle futures are gaining steam from the cash market, with February up $1.10 at midday. April is up 7 cents with other contracts lower. Cash trade has came in a $238-240 live across the country and $375-378 dressed. The Friday morning Fed Cattl...
Amgen ends its rocatinlimab partnership, returning control to Kyowa Kirin, citing strategy changes, weaker Phase 3 results and safety concerns that raised doubts about the drug's commercial future.
ResMed beat earnings and revenue estimates as sales rose 11% and margins expanded. Analysts backed long-term growth and raised price targets despite competition concerns.
FDA approved Tenpoint's Yuvezzi eye drop for presbyopia, adding competition for LENZ's VIZZ as analysts say the recent stock drop may be overdone and see blockbuster potential ahead.
